Ovarian reserve in young juvenile idiopathic arthritis patients

Nenhuma Miniatura disponível
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Citação
MODERN RHEUMATOLOGY, v.29, n.3, p.447-451, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: Juvenile idiopathic arthritis (JIA) occurs during reproductive age, however, there are no systematic data regarding ovarian function in this disease. Methods: Twenty-eight post-pubertal JIA patients and age-matched 28 healthy controls were studied. Complete ovarian function was assessed during the early follicular phase of the menstrual cycle including anti-Mullerian hormone (AMH), estradiol, luteinizing hormone (LH), follicle-stimulating hormone (FSH) and antral follicle count (AFC) by ovarian ultrasound, and anti-corpus lutheum antibodies (anti-CoL). Demographic data, menstrual abnormalities, disease parameters and treatment were also evaluated. Results: The mean current age (22.6 +/- 6.59 vs. 22.5 +/- 6.59 years, p = .952) was similar in JIA patients and healthy controls with a higher median menarche age [13(8-16) vs. 12(8-14) years, p = .029]. A lower median AMH levels [2.65(0.47-9.08) vs. 4.83(0.74-17.24) ng/mL, p = .029] with a higher LH [8.44 +/- 4.14 vs. 6.03 +/- 2.80 IU/L, p = .014] and estradiol levels [52.3(25.8-227.4) vs. 38.9(26.2-133.6) pg/mL, p = .008] were observed in JIA compared to control group. Anti-CoL and AFC were similar in both groups (p > .05). Further analysis of JIA patients revealed that current age, disease duration, number of active/limited joints, ESR, CRP, patient/physician VAS, JADAS 71, DAS 28, CHAQ, HAQ, patient/parents PedsQL, PF-SF 36, cumulative glucocorticoid and cumulative methotrexate doses were not correlated with AMH, FSH, estradiol levels or AFC (p > .05). Conclusion: The present study was the first to suggest diminished ovarian reserve, not associated to hypothalamic pituitary gonadal axis, in JIA patients during reproductive age. The impact of this dysfunction in future fertility of these patients needs to be evaluated in prospective studies.
Palavras-chave
Juvenile idiopathic arthritis, ovarian reserve, anti-Mullerian hormone, fertility, anti-corpus lutheum antibodies
Referências
  1. Aikawa NE, 2012, CLIN EXP RHEUMATOL, V30, P445
  2. Aikawa NE, 2010, CLIN EXP RHEUMATOL, V28, P571
  3. Almeida PM, 1991, CRITERIO CLASSE EC A, P1
  4. Brouwer J, 2013, ARTHRIT CARE RES, V65, P1534, DOI 10.1002/acr.22013
  5. de Souza FHC, 2015, CLIN RHEUMATOL, V34, P1795, DOI 10.1007/s10067-015-3064-1
  6. Ciconelli RM, 1999, RER BRAS RHEUMATOL, V39, P3
  7. Cohen J, 2015, J ASSIST REPROD GEN, V32, P1709, DOI 10.1007/s10815-015-0595-y
  8. Consolaro A, 2009, ARTHRIT RHEUM-ARTHR, V61, P658, DOI 10.1002/art.24516
  9. DAVID J, 1993, CLIN EXP RHEUMATOL, V11, P85
  10. de Araujo DB, 2014, SCAND J RHEUMATOL, V43, P503, DOI 10.3109/03009742.2014.908237
  11. de Souza FHC, 2015, CLIN EXP RHEUMATOL, V33, P44
  12. Febronio MV, 2007, LUPUS, V16, P430, DOI 10.1177/0961203307079298
  13. FERRAZ MB, 1990, J RHEUMATOL, V17, P813
  14. Gualano B, 2017, NAT REV RHEUMATOL, V13, P368, DOI 10.1038/nrrheum.2017.75
  15. Hendriks DJ, 2007, FERTIL STERIL, V87, P764, DOI 10.1016/j.fertnstert.2006.11.006
  16. Hendriks DJ, 2005, FERTIL STERIL, V83, P291, DOI 10.1016/j.fernstert.2004.10.011
  17. Henes M, 2015, RHEUMATOLOGY, V54, P1709, DOI 10.1093/rheumatology/kev124
  18. Karakus S, 2017, J OBSTET GYNAECOL RE, V43, P303, DOI 10.1111/jog.13216
  19. Klatchoian DA, 2008, J PEDIAT-BRAZIL, V84, P308, DOI [10.2223/JPED.1788, 10.1590/S0021-75572008000400005]
  20. Kristensen SL, 2012, FERTIL STERIL, V97, P779, DOI 10.1016/j.fertnstert.2011.12.017
  21. Machado CSM, 2001, CLIN EXP RHEUMATOL, V19, pS25
  22. Medeiros PB, 2009, LUPUS, V18, P38, DOI 10.1177/0961203308094652
  23. Mont'Alverne ARS, 2015, CLIN RHEUMATOL, V34, P179, DOI 10.1007/s10067-014-2680-5
  24. Mont'Alverne ARS, 2014, J RHEUMATOL, V41, P2055, DOI 10.3899/jrheum.131360
  25. Ostensen M, 2011, RHEUMATOLOGY, V50, P657, DOI 10.1093/rheumatology/keq350
  26. Packham JC, 2003, CLIN EXP RHEUMATOL, V21, P347
  27. Pasoto SG, 1999, J RHEUMATOL, V26, P1087
  28. Petty RE, 2004, J RHEUMATOL, V31, P390
  29. Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1407, DOI 10.1016/j.fertnstert.2012.09.036
  30. Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4
  31. Pugliese C, 2016, CLIN RHEUMATOL, V35, P81, DOI [10.1007/s10067-01-3125-5, 10.1007/s10067-015-3125-5]
  32. Silva CA, 2014, AUTOIMMUN REV, V13, P427, DOI 10.1016/j.autrev.2014.01.003
  33. Silva CAA, 2007, LUPUS, V16, P593, DOI 10.1177/096120330707077538
  34. Silva CAA, 2002, LUPUS, V11, P419, DOI 10.1191/0961203302lu219oa
  35. Silva CA, 2010, ARTHRIT CARE RES, V62, P1682, DOI 10.1002/acr.20323
  36. van Riel PLCM, 2014, CLIN EXP RHEUMATOL, V32, pS65
  37. Yamakami LYS, 2015, LUPUS, V24, P1007, DOI 10.1177/0961203315591029
  38. Yamakami LYS, 2014, LUPUS, V23, P862, DOI 10.1177/0961203314529468
  39. Yamakami LYS, 2011, LUPUS, V20, P523, DOI 10.1177/0961203310383300